Virtus ETF Advisers’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-656
| Closed | -$59.5K | – | 486 |
|
|
2023
Q1 | $59.5K | Sell |
656
-253
| -28% | -$22.9K | 0.03% | 422 |
|
|
2022
Q4 | $107K | Buy |
+909
| New | +$107K | 0.06% | 437 |
|
|
2022
Q2 | – | Sell |
-455
| Closed | -$71K | – | 482 |
|
|
2022
Q1 | $71K | Sell |
455
-27
| -6% | -$4.21K | 0.03% | 350 |
|
|
2021
Q4 | $143K | Buy |
482
+75
| +18% | +$22.3K | 0.05% | 359 |
|
|
2021
Q3 | $235K | Sell |
407
-21
| -5% | -$12.1K | 0.1% | 227 |
|
|
2021
Q2 | $195K | Buy |
428
+103
| +32% | +$46.9K | 0.08% | 360 |
|
|
2021
Q1 | $175K | Buy |
325
+6
| +2% | +$3.23K | 0.07% | 340 |
|
|
2020
Q4 | $282K | Buy |
+319
| New | +$282K | 0.12% | 244 |
|